Literature DB >> 11841312

Proton-transfer dynamics in the activation of cytochrome P450eryF.

Victor Guallar1, Danni L Harris, Victor S Batista, William H Miller.   

Abstract

Molecular dynamics simulations are combined with quantum chemistry calculations of instantaneous proton-transfer energy profiles to investigate proton-transfer events in the transient pathway of cytochrome P450eryF (6-deoxyerythronolide B hydroxylase; CYP107A1), from the oxyferrous species to the catalytically active ferryl oxygen species (compound I). This reaction is one of the most fundamental unresolved aspects in the mechanism of oxidation that is common to all cytochrome P450s. We find that this process involves an ultrafast proton transfer from the crystallographic water molecule W519 to the distal oxygen bound to the heme group, and a subsequent proton-transfer event from W564 to W519. Both proton-transfer events are found to be endothermic in the oxyferrous state, suggesting that the oxyferrous reduction is mechanistically linked to the proton-transfer dynamics. These findings indicate that the hydrogen bond network, proximate to the O(2)-binding cleft, plays a crucial functional role in the enzymatic activation of P450s. Our results are consistent with the effect of mutations on the enzymatic efficacy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11841312     DOI: 10.1021/ja016474v

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  8 in total

1.  Role of the Proximal Cysteine Hydrogen Bonding Interaction in Cytochrome P450 2B4 Studied by Cryoreduction, Electron Paramagnetic Resonance, and Electron-Nuclear Double Resonance Spectroscopy.

Authors:  Roman Davydov; Sangchoul Im; Muralidharan Shanmugam; William A Gunderson; Naw May Pearl; Brian M Hoffman; Lucy Waskell
Journal:  Biochemistry       Date:  2016-02-03       Impact factor: 3.162

2.  The first step of the dioxygenation reaction carried out by tryptophan dioxygenase and indoleamine 2,3-dioxygenase as revealed by quantum mechanical/molecular mechanical studies.

Authors:  Luciana Capece; Ariel Lewis-Ballester; Dipanwita Batabyal; Natali Di Russo; Syun-Ru Yeh; Dario A Estrin; Marcelo A Marti
Journal:  J Biol Inorg Chem       Date:  2010-04-02       Impact factor: 3.358

3.  Complete reaction mechanism of indoleamine 2,3-dioxygenase as revealed by QM/MM simulations.

Authors:  Luciana Capece; Ariel Lewis-Ballester; Syun-Ru Yeh; Dario A Estrin; Marcelo A Marti
Journal:  J Phys Chem B       Date:  2012-01-23       Impact factor: 2.991

4.  Compound I is the reactive intermediate in the first monooxygenation step during conversion of cholesterol to pregnenolone by cytochrome P450scc: EPR/ENDOR/cryoreduction/annealing studies.

Authors:  Roman Davydov; Andrey A Gilep; Natallia V Strushkevich; Sergey A Usanov; Brian M Hoffman
Journal:  J Am Chem Soc       Date:  2012-10-05       Impact factor: 15.419

5.  Comparison of the Mechanisms of Heme Hydroxylation by Heme Oxygenases-1 and -2: Kinetic and Cryoreduction Studies.

Authors:  Roman Davydov; Angela S Fleischhacker; Ireena Bagai; Brian M Hoffman; Stephen W Ragsdale
Journal:  Biochemistry       Date:  2015-12-23       Impact factor: 3.162

6.  Peripheral heme substituents control the hydrogen-atom abstraction chemistry in cytochromes P450.

Authors:  Victor Guallar; Mu-Hyun Baik; Stephen J Lippard; Richard A Friesner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-27       Impact factor: 11.205

7.  On the role of the axial ligand in heme proteins: a theoretical study.

Authors:  Patrik Rydberg; Emma Sigfridsson; Ulf Ryde
Journal:  J Biol Inorg Chem       Date:  2004-01-15       Impact factor: 3.358

8.  Evidence That Compound I Is the Active Species in Both the Hydroxylase and Lyase Steps by Which P450scc Converts Cholesterol to Pregnenolone: EPR/ENDOR/Cryoreduction/Annealing Studies.

Authors:  Roman Davydov; Natallia Strushkevich; David Smil; Aliaksei Yantsevich; Andrey Gilep; Sergey Usanov; Brian M Hoffman
Journal:  Biochemistry       Date:  2015-11-25       Impact factor: 3.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.